TrivarX Limited (ASX:TRI)
0.0130
+0.0010 (8.33%)
Last updated: Apr 28, 2025
TrivarX Revenue
TrivarX had revenue of 1.13M AUD in the half year ending December 31, 2024, with 17.55% growth. This brings the company's revenue in the last twelve months to 2.00M, up 9,105.58% year-over-year. In the fiscal year ending June 30, 2024, TrivarX had annual revenue of 888.83K, down -7.46%.
Revenue (ttm)
2.00M
Revenue Growth
+9,105.58%
P/S Ratio
3.71
Revenue / Employee
332.69K
Employees
6
Market Cap
7.41M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 888.83K | -71.62K | -7.46% |
Jun 30, 2023 | 960.45K | -45.00K | -4.48% |
Jun 30, 2022 | 1.01M | -258.10K | -20.43% |
Jun 30, 2021 | 1.26M | 338.28K | 36.56% |
Jun 30, 2020 | 925.27K | -3.18M | -77.44% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Telix Pharmaceuticals | 783.21M |
Ramsay Health Care | 17.12B |
Ansell | 3.00B |
Mesoblast | 9.16M |